127. Living on the Edge: The Impact of MIC Distributions on Empiric Antibiotic Selection

por Bauer, Karri A, Hidayat, Levita K, Klinker, Kenneth, Motyl, Mary, Andrew DeRyke, C
Publicado 2021

151. Simplifying Empiric Antimicrobial Therapy Selection for Lower Respiratory Tract Infections in Intensive Care Unit Patients: Using Resistance Frequency to Guide Decision Making

por Klinker, Kenneth, Hidayat, Levita K, Andrew DeRyke, C, Motyl, Mary, Bauer, Karri A
Publicado 2021

1273. Activity of Ceftolozane/Tazobactam and Comparators Against Enterobacterales and P. aeruginosa Isolates from Pediatric Patients—SMART United States 2017-2019

por Lob, Sibylle, Hackel, Meredith, Andrew DeRyke, C, Harris, Kelly, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Publicado 2021

1080. Relebactam Increases Imipenem Activity Against Imipenem-Nonsusceptible and -Susceptible Pseudomonas aeruginosa and Enterobacterales: Assessment of Isolates from RESTORE-IMI 2

por Hilbert, David W, Andrew DeRyke, C, Losada, Maria C, Moise, Pamela, Chen, Luke F, Young, Katherine
Publicado 2021

1274. Activity of Ceftolozane/Tazobactam, Imipenem/Relebactam, and Comparators Against Pseudomonas aeruginosa Isolates from Patients with Bloodstream and Other Infection Types—SMAR...

por Lob, Sibylle, Hackel, Meredith, Andrew DeRyke, C, Harris, Kelly, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Publicado 2021